<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mandal J</submitter><funding>NIDDK NIH HHS</funding><funding>NHLBI NIH HHS</funding><pagination>1729-1742</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12444880</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>82(10)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Previously, we demonstrated that the ketone body, β-hydroxybutyrate, is a potent antihypertensive and reno-protective metabolite in Dahl Salt-Sensitive rats. However, the mechanism by which β-hydroxybutyrate confers these beneficial effects is understudied. Here we focused on determining whether the reno-protective effect of β-hydroxybutyrate is due to its known ability to epigenetically remodel chromatin via histone β-hydroxybutyrylation.&lt;h4>Methods&lt;/h4>We used the same animal protocol previously used for the discovery of the reno-protective effect of β-hydroxybutyrate. Briefly, postweaning, male and female Dahl Salt-Sensitive rats were split into 2 groups and supplemented with or without 1,3-butanediol for 6 weeks. At euthanasia, circulating β-hydroxybutyrate was quant</pubmed_abstract><journal>Hypertension (Dallas, Tex. : 1979)</journal><pubmed_title>Epigenetic Histone β-Hydroxybutyrylation Contributes to Renoprotection by β-Hydroxybutyrate in the Dahl Rat.</pubmed_title><pmcid>PMC12444880</pmcid><funding_grant_id>R01 HL171401</funding_grant_id><funding_grant_id>R01 DK134053</funding_grant_id><funding_grant_id>R01 HL143082</funding_grant_id><pubmed_authors>Joe B</pubmed_authors><pubmed_authors>Mandal J</pubmed_authors><pubmed_authors>Mei X</pubmed_authors><pubmed_authors>Tummala R</pubmed_authors><pubmed_authors>Kleinhenz A</pubmed_authors><pubmed_authors>Aryal S</pubmed_authors><pubmed_authors>de la Serna I</pubmed_authors><pubmed_authors>Manandhar I</pubmed_authors><pubmed_authors>Basrur V</pubmed_authors><pubmed_authors>Gunning WT</pubmed_authors><pubmed_authors>Chakraborty S</pubmed_authors><pubmed_authors>Yeoh BS</pubmed_authors><pubmed_authors>Yang T</pubmed_authors><pubmed_authors>Mell B</pubmed_authors><pubmed_authors>Saha P</pubmed_authors><pubmed_authors>Vijay-Kumar M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Epigenetic Histone β-Hydroxybutyrylation Contributes to Renoprotection by β-Hydroxybutyrate in the Dahl Rat.</name><description>&lt;h4>Background&lt;/h4>Previously, we demonstrated that the ketone body, β-hydroxybutyrate, is a potent antihypertensive and reno-protective metabolite in Dahl Salt-Sensitive rats. However, the mechanism by which β-hydroxybutyrate confers these beneficial effects is understudied. Here we focused on determining whether the reno-protective effect of β-hydroxybutyrate is due to its known ability to epigenetically remodel chromatin via histone β-hydroxybutyrylation.&lt;h4>Methods&lt;/h4>We used the same animal protocol previously used for the discovery of the reno-protective effect of β-hydroxybutyrate. Briefly, postweaning, male and female Dahl Salt-Sensitive rats were split into 2 groups and supplemented with or without 1,3-butanediol for 6 weeks. At euthanasia, circulating β-hydroxybutyrate was quant</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Oct</publication><modification>2026-07-16T18:42:34.873Z</modification><creation>2026-07-11T03:08:21.629Z</creation></dates><accession>S-EPMC12444880</accession><cross_references><pubmed>40726393</pubmed><doi>10.1161/HYPERTENSIONAHA.125.25251</doi></cross_references></HashMap>